KVD001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KVD001, covering 2017-03-03 to 2020-12-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) [Phase 2]